Le Lézard
Classified in: Health
Subjects: SVY, PET, ANW

Purina Seeks Research Proposals from Pet-Loving Scientists to Study the Human-Animal Bond


Funding Available to Help Scientists Investigate the Human-Pet Connection and the
Healing Power of Dogs and Cats

ST. LOUIS, April 26, 2023 /PRNewswire/ -- The scientists and pet experts at Purina are seeking grant proposals from  researchers interested in studying the unique and powerful bond between pets and people. The bi-annual Purina Sponsorship for Human-Animal Bond studies program provides up to $30,000 in research funding per project. The application period is open until July 15, 2023.

Preferences will be given to proposals exploring the potential benefits of the human-pet bond in the following areas:

1.  Mental health

2.  Shelter pets and adoption

3.  Pets and youth

"Everything we do at Purina is based on science and research and working with the scientific community to grow our collective knowledge about the power of pets in society is part of our DNA," said Francois Martin, M.A., Ph.D., Manager, Global Pet Behavior and Welfare at Purina. "There is no doubt that pets make our lives better. Continued research helps us understand all of the ways we benefit from them at home and far beyond."

With 500 pet nutritionists, veterinarians, behaviorists and other credentialed pet experts on staff, Purina invests more than $100 million in research each year. This research has led to countless groundbreaking innovations to help pets live, longer, healthier lives.

Rules for 2024 Sponsorship Applications

Researchers interested in applying and getting more details can visit www.purina.com/HumanAnimalBond. Completed applications must be sent to [email protected].

About Purina
Nestlé Purina PetCare creates richer lives for pets and the people who love them. Founded in 1894, Purina has helped dogs and cats live longer, healthier lives by offering scientifically based nutritional innovations. Purina manufactures some of the world's most trusted and popular pet care products, including Purina ONE, Pro Plan, Fancy Feast and Tidy Cats. Our more than 10,000 U.S. associates take pride in our trusted pet food, treat and litter brands that feed 51 million dogs and 65 million cats every year. More than 500 Purina scientists, veterinarians, and pet care experts ensure our commitment to unsurpassed quality and nutrition.

Purina promotes responsible pet care through our scientific research, our products and our support for pet-related organizations. Over the past five years, Purina has contributed more than $150 million towards organizations that bring, and keep, people and pets together, as well as those that help our communities and environment thrive.

Purina is part of Nestlé, a global leader in Nutrition, Health and Wellness. For more information, visit purina.com or subscribe here to get the latest Purina news.

SOURCE Nestle Purina PetCare


These press releases may also interest you

at 05:05
Sphere Fluidics, a leading provider of innovative microfluidics-based solutions for single-cell analysis and isolation, today announced the appointment of Dale Levitzke as CEO with immediate effect, as Dr. Frank F. Craig, current CEO and co-founder,...

at 05:05
Scenic Biotech, a pioneer in the field of modifier therapies for severe genetic disorders, today announced that it has entered into a research collaboration with Bristol Myers Squibb to accelerate the development of Bristol Myers Squibb's drug...

at 05:00
As PetSafe® continues to lead the way in pet-tech innovations, we are proud to introduce the next evolution in pet fountains: the PetSafe® Outlasttm 90 oz Pumpless Pet Fountain with patented HydroSpintm technology....

at 05:00
BioMed X, a German biomedical research institute, announces the start of a new research project in partnership with Merck at its site in Heidelberg, Germany. The main objective of the project is to develop novel immunotherapeutic strategies to...

at 04:52
Foresee Pharmaceuticals (TPEx: 6576), ("Foresee") today announced that the first subject has been dosed in its Phase 1 clinical trial of FP-020 in Australia. The Phase 1 clinical trial is a randomized, double-blind, placebo-controlled,...

at 04:09
A news report from China Daily: The 2024 ZGC Forum in Beijing showcased a wide range of latest technological innovations. The event ran from April 25 to 29 and comprised 128 activities, including forums and conferences, technology exchanges,...



News published on and distributed by: